Literature DB >> 16697003

Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling.

Samarjit Das1, Hajime Otani, Nilanjana Maulik, Dipak K Das.   

Abstract

A recent study documented reactive oxygen species (ROS), generated through NADPH oxidase by angiotensin II (Ang II) with the activation of NADPH oxidase subunits, p22phox and gp91phox, to be responsible for the preconditioning effect of Ang II. The present study was designed to determine if similar to ischemic preconditioning (PC), mitogen-activated protein (MAP) kinases are also involved in Ang II PC of the heart. Isolated working rat hearts were perfused for 15 min with KHB (Krebs-Henseleit bicarbonate) buffer containing Ang II in the absence or presence of an Erk (1/2) inhibitor, PD 098059, a p38MAPK inhibitor, SB 202190, a JNK inhibitor, SP 600125 or a ROS scavenger, N-acetyl cysteine (NAC). All hearts were subsequently subjected to 30 min global ischemia followed by 2 h reperfusion with KHB buffer only. Cardioprotection was examined by determining infarct size, cardiomyocyte apoptosis and ventricular recovery. Redox and MAP kinase regulation were studied by determining the survival signaling mediated by Akt and Bcl-2. In consistent with previous results, Ang II preconditioned the heart as evidenced by improved postischemic ventricular recovery and reduced infarct size and decreases cardiomyocyte apoptosis. Ang II phosphorylated both Akt, Bcl-2 and Bad, which was blocked by NAC, PD 098059 or SP 600125, but not by SB 202190. NAC, PD 098059 and SP600125, but not SB202190, also abolished the cardioprotective effect of Ang II preconditioning. The results indicate that Ang II preconditioning is potentiated through MAP kinases that are regulated by redox signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16697003     DOI: 10.1016/j.yjmcc.2006.03.009

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  16 in total

1.  NADPH oxidase modulates myocardial Akt, ERK1/2 activation, and angiogenesis after hypoxia-reoxygenation.

Authors:  Jian-Xiong Chen; Heng Zeng; Qin-Hui Tuo; Heidi Yu; Barbara Meyrick; Judy L Aschner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-01-12       Impact factor: 4.733

Review 2.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

3.  Generation of survival signal by differential interaction of p38MAPKalpha and p38MAPKbeta with caveolin-1 and caveolin-3 in the adapted heart.

Authors:  Manika Das; Jianhua Cui; Dipak K Das
Journal:  J Mol Cell Cardiol       Date:  2006-10-25       Impact factor: 5.000

4.  Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.

Authors:  Gang Chen; Shi-qi Pan; Cong Shen; Shi-fen Pan; Xiu-min Zhang; Qi-yang He
Journal:  Acta Pharmacol Sin       Date:  2014-03-10       Impact factor: 6.150

5.  Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.

Authors:  Eric E Essick; Noriyuki Ouchi; Richard M Wilson; Koji Ohashi; Joanna Ghobrial; Rei Shibata; David R Pimentel; Flora Sam
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-10       Impact factor: 4.733

6.  Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells.

Authors:  Kenichiro Koda; Mariselis Salazar-Rodriguez; Federico Corti; Noel Yan-Ki Chan; Racha Estephan; Randi B Silver; Daria Mochly-Rosen; Roberto Levi
Journal:  Circulation       Date:  2010-08-09       Impact factor: 29.690

7.  Sevoflurane postconditioning protects isolated rat hearts against ischemia-reperfusion injury: the role of radical oxygen species, extracellular signal-related kinases 1/2 and mitochondrial permeability transition pore.

Authors:  Yun-Tai Yao; Li-Huan Li; Lei Chen; Wei-Peng Wang; Li-Bing Li; Chang-Qing Gao
Journal:  Mol Biol Rep       Date:  2009-08-20       Impact factor: 2.316

8.  Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion.

Authors:  Dake Qi; Xiaoyue Hu; Xiaohong Wu; Melanie Merk; Lin Leng; Richard Bucala; Lawrence H Young
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

9.  Adenosine A3 receptor deficiency exerts unanticipated protective effects on the pressure-overloaded left ventricle.

Authors:  Zhongbing Lu; John Fassett; Xin Xu; Xinli Hu; Guangshuo Zhu; Joel French; Ping Zhang; Jurgen Schnermann; Robert J Bache; Yingjie Chen
Journal:  Circulation       Date:  2008-10-06       Impact factor: 29.690

10.  The effects of ginsenoside Rb1 on JNK in oxidative injury in cardiomyocytes.

Authors:  Jing Li; Zuo-Hui Shao; Jing-Tian Xie; Chong-Zhi Wang; Srinivasan Ramachandran; Jun-Jie Yin; Han Aung; Chang-Qing Li; Gina Qin; Terry Vanden Hoek; Chun-Su Yuan
Journal:  Arch Pharm Res       Date:  2012-08-03       Impact factor: 4.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.